Pressure is a modifiable treatment target, not a sufficient diagnosis. Use the angle, structural and functional findings to classify disease and plan individual follow-up.
Terminology and draft status
Terminology review is not complete. No new WHO UMD entry verification is claimed; pending entries and limits are recorded in terminology.md.
01Establish the baseline before classifying glaucoma
When glaucoma is suspected, assess six areas: history, intraocular pressure (IOP), drainage angle, optic disc, retinal nerve fibre layer (RNFL) and visual field. The disc is the visible optic nerve head; the visual field tests visual function. 2 4
Then ask: Is damage already present? Is glaucoma suspected? Or is only the risk increased? One pressure reading, a large cup or a red OCT mark cannot answer this alone. 2 4
Ask about family glaucoma, previous pressures, operations, myopia and eye injuries. Review all medicines, especially corticosteroids as drops, tablets or other preparations. 3
Check previous results and treatment. Look for pseudoexfoliation material and pigment dispersion at the slit lamp. Symptoms and systemic disease help determine urgency and later treatment. 3
Ocular hypertension (OHT) means raised pressure without demonstrated glaucomatous damage. Pressure, disc appearance, OCT or visual fields may raise suspicion of glaucoma. 2
In preperimetric glaucoma, convincing structural damage is present without a typical visual field defect yet. Before using this diagnosis, check for measurement errors and other optic nerve diseases. 2
02Connect nerve anatomy with the clinical findings
The camera analogy uses cornea/lens as optics, retina as film and the optic nerve as a cable to the brain. Glaucoma damages retinal ganglion cells and axons; treatment aims to preserve remaining function, not restore every lost fibre. Pressure reduction is like braking only in the sense of reducing risk: the original 2–3 monthprogression lag is not a validated safe waiting period for every eye. Confirm suspected progression promptly and reassess target and treatment. 1 2
The collagenous lamina cribrosa supports axons at the optic-nerve exit. Larger superior/inferior pores and connective-tissue architecture are proposed contributors to regional vulnerability, not an individual deterministic prediction. Assess rim/RNFL loss, the ISNT teaching pattern and vertical/hourglass excavation in context. Papillomacular bundle involvement can affect central function; atypical pallor or field patterns need another-cause assessment. 1
Superficial RNFL perfusion and deeper prelaminar/laminar/retrolaminar circulation involve central retinal and posterior ciliary arterial systems with regional overlap; the Zinn–Haller ring is an anatomical teaching landmark. No-light-perception(NLP) versus hand-movements(HM) acuity does not reliably localise an occlusion to ciliary versus central retinal arteries. Sudden severe loss needs urgent retinal/neurovascular assessment, not this shortcut. 1
03Understand aqueous production, outflow and posture
Aqueous production depends largely on active secretion by nonpigmented ciliary epithelium, with ultrafiltration and diffusion contributing. The original approximately 80 processes,200–300µlvolume/100 minute turnover and 80–90% activetransport are approximate teaching values, not fixed measurements in each eye. Carbonic-anhydrase inhibitors and beta blockers reduce production by different pharmacological mechanisms; effects and contraindications require the actual drug information. 1
Pressure reflects the balance of production, conventional trabecular and other outflow routes and downstream pressure. Supine position can increase IOP; prolonged steep Trendelenburg in selected operations can cause substantial rises. The original 50–60 mmHg is not a normal value for lying down or every robotic case. An original fluctuation up to 10 mmHg is an example, not a universal physiological allowance or a reason to ignore high readings. 1
| Mechanism | Description | Clinical / drug context |
|---|---|---|
| Active transport | Energy-dependent secretion; original 80–90% is approximate | Carbonic-anhydrase inhibitors/beta blockers reduce production through different mechanisms. |
| Ultrafiltration | Pressure/perfusion gradients contribute | Blood/capillary and intraocular pressures interact; not a single treatment rule. |
| Diffusion | Passive movement along a gradient | A physiological component, not a standalone routine glaucoma-treatment target. |
04Separate angle mechanism, damage and risk
In open-angle glaucoma the “door is open” but outflow resistance is increased; pseudoexfoliation (PEX) and pigment dispersion are possible secondary contexts. In angle closure the “door” is obstructed by iridotrabecular contact, which may be appositional or synechial. Extent such as the original>180°requires clinical classification with pressure, PAS and optic-nerve damage; angle closure alone is not synonymous with glaucomatous neuropathy. 1 2 5
Original global 80 million/~3% figures are undated population estimates here, not verified current all-age rates. Family history, higher myopia and ancestry/population patterns can inform risk, but the original 22% family-risk statement has no clear absolute-versus-relative definition. Higher observed OAG burden in some African-ancestry populations and closure burden in some Asian populations do not diagnose an individual. Unilateral/asymmetric disease also prompts assessment for PEX, trauma, tumour or another secondary cause. 1
05Measure pressure and check the corneal context
Goldmann applanation tonometry (GAT) is the clinical reference method. It measures the force needed to flatten a defined corneal area. The Imbert–Fick principle explains this in a simplified model; a real cornea does not fully fit that model. 2
Check calibration, fluorescein amount and alignment of the semicircles. Keep the patient relaxed. Fluorescein rings ('mires') that are too broad or narrow can alter the reading. 2
Hold the lids open without pressing on the globe. Ask the patient to breathe normally and avoid straining. Posture and time of day also affect pressure; a fixed 6 mmHg addition is inappropriate. 2
Repeat an unexpected reading under good conditions. High pressure with pain or sudden visual loss requires urgent assessment. 2
CCT means central corneal thickness. Thickness, curvature and mechanical properties affect pressure measurement. Interpret readings especially carefully after refractive surgery or with corneal oedema. 2 8
Measure CCT and record it alongside the measured IOP. A blanket formula cannot give a reliably 'true' pressure. A value within the statistical normal range does not exclude glaucoma. 2 8
Other tonometers can help in children, difficult positioning or unusual corneas. Record device, model and measurement conditions during follow-up. 2
GAT applanates a 3.06 mm diameter area; this is not the outside diameter of the prism. Excess or insufficient fluorescein, lid pressure, Valsalva/straining and tight neck clothing can alter readings. Corneal oedema can make an apparent 25 mmHg misleading, sometimes underestimating pressure; neither the size nor direction of error is reliably corrected by a universal formula. 1 2
Rebound iCare can be helpful in children and avoids topical anaesthesia in many settings; Tono-Pen may help with positioning or an irregular cornea. Neither is universally ideal, and noncontact air-puff is not confined to one diagnostic role regardless of model. Confirm unexpected findings with an appropriate method and record device and conditions. 1 2
06Inspect the angle before choosing the mechanism-specific treatment
Gonioscopy asks: Is the angle open, narrow or closed? Is there a secondary cause of raised pressure? A normal central anterior chamber, the disc or IOP cannot answer this. 2 4
Use dim light and document all four quadrants. Excessive light or lens pressure can artificially open a narrow angle. 2 4
Identify Schwalbe's line, trabecular meshwork, scleral spur and ciliary body band. Record angle width, pigment, abnormal vessels and signs of trauma or pigment dispersion. PAS are peripheral anterior synechiae: adhesions between iris and angle. 2
During indentation, apply gentle pressure with a suitable gonioscopy lens. Appositional closure may open; an adhesion remains. Examine the angle without indentation too. 2
Van Herick estimates peripheral anterior chamber depth at the slit lamp. AS-OCT images the anterior segment. UBM means ultrasound biomicroscopy and also shows structures behind the iris. 2
These methods complement gonioscopy. They do not assess pigment, synechiae and secondary causes in the same way. A narrow-angle AS-OCT image alone should not determine treatment. 2
The corneal-wedge technique follows anterior/posterior corneal reflections to their meeting at Schwalbe’s line, helping with lightly pigmented angles. Zeiss/Sussman-type small-contact-area lenses permit gentle indentation: appositional contact may open, while PAS persist. Excess pressure, incomplete viewing and illumination can mislead; an angle that remains closed is not alone proof that all of it is synechial. Look specifically for angle neovascularisation(NVA). 1 2
07Set an individual target and investigate discordant findings
Baseline diagnosis combines history, acuity/pupils, pressure with method/time, pachymetry, gonioscopy, disc/RNFL assessment and reliable perimetry; original OCT images and photographs support comparison. The statistical 10–21 mmHg range is not a target for every eye. Damage, rate of progression, life expectancy, treatment tolerance and patient circumstances guide the target and interval; pressure remains the principal proven modifiable therapeutic target, not the entire disease. 1 2 5
Initial SLT is an option for selected treatment-naïve OAG/OHT with an accessible suitable angle, not a universal equivalent for every glaucoma. In the historical 6 yearLiGHTappraisal,69.8% of initially SLT-treated eyes remained at target without drops/incisional surgery and progression was 19.6% versus 26.8% with initial drops. General EQ-5D/GUI/GQL-15 differences were not significant, GSS symptoms favoured SLT;73% retention and crossover after 3 years limit a pure long-term comparison. The located 2025 corrigendum has not been fully assessed here. 6 7
Do not apply fixed 6 monthpressure/morphology and annualfield intervals to every patient. Repeat or intensify assessment when progression, treatment change or uncertainty warrants it. Disproportionate pallor, atypical central/vertical field loss or neurological symptoms can reflect compressive, vascular or nutritional optic neuropathy, including tumour, stroke or vitamin deficiency; investigate according to the actual findings rather than calling all such cases glaucoma. 1 2 5
| Topic | Clinical concept | Assessment / action | Original figures / limits | Warning signs |
|---|---|---|---|---|
| Anatomy | Lamina-related regional vulnerability | Assess rim and RNFL with function | Original 22% family-risk estimate undefined | Unilateral/asymmetric disease: assess PEX, trauma, tumour or another cause. |
| Tonometry | Dynamic IOP; braking is an analogy | GAT and measurement quality | 3.06 mm is applanated diameter;2–3 monthlag not a safe waiting rule | Oedema can mislead; investigate symptoms and unexpected readings. |
| Gonioscopy | Apposition versus PAS with gentle indentation | Baseline angle and secondary causes | Original>180°extent alone does not define glaucoma | Angle neovascularisation(NVA) requires urgent cause-directed assessment. |
| Physiology | Predominantly active aqueous secretion | Individual target rather than statistical normality | Original fluctuation up to 10 mmHg is not universal | Review steroid exposure/response and changing risk. |
| Differential diagnosis | Other optic neuropathy can mimic glaucoma | Investigate discordant pallor/function | Original 80 millionglobal estimate is undated | Consider compression, stroke/ischaemia or nutritional deficiency when findings warrant. |
What are the main learning points?
Pressure is a modifiable treatment target, not a sufficient diagnosis. Use the angle, structural and functional findings to classify disease and plan individual follow-up.
When is assessment urgent?
Sudden visual loss, severe pain, a red eye with high pressure, new neurological signs or suspected neovascular angle closure needs urgent assessment. Do not wait 2–3 months because of a braking metaphor.
References and access status
- 1Immutable original export; own complete glaucoma foundations/gonioscopy export
Complete export read; original attribution and any recording/transcript or appointment not independently verified.
- 2EGS. Terminology and Guidelines for Glaucoma, 6th edition (2025). DOI: 10.1136/bjophthalmol-2025-egsguidelines.
Historical 005 source record (3–6 October 2026), not new full-source access: Full guideline inspected: clinical diagnosis, tonometry, disc, OCT, gonioscopy, visual field and individual target pressure. Published 8 September 2025.
- 3DOG/BVA. S2e Bewertung von Risikofaktoren für das Auftreten des Offenwinkelglaukoms, AWMF 045-015 (3 March 2024).
Historical 005 source record (3–6 October 2026), not new full-source access: Full text inspected. Risk factors and early detection; not a comprehensive treatment guideline. Distinguish recommendation strength from evidence level.
- 4NICE NG 81. Glaucoma: diagnosis and management (updated 26.01.2022).
Historical 005 source record (3–6 October 2026), not new full-source access: Current recommendations inspected, sections 1.1.4–1.1.5, 1.2.1 and 1.4.4. 24 mmHg is a context-dependent threshold, not a universal diagnostic or target pressure.
- 5AAO. Glaucoma Summary Benchmarks for Preferred Practice Pattern Guidelines (December 2025), pp. 1–9.
Historical 005 source record (3–6 October 2026), not new full-source access: Supplied original PDF read in full on 6 October 2026: diagnosis pp. 3/6, follow-up and consensus interval table p. 5, angle closure pp. 8–9. Official summary, not the full PPP. The 2020 in the stable AAO URL is not the edition date of the linked 2025 benchmark.
- 6LiGHT 6-year RCT: initial SLT versus drops, treatment-naïve OAG/OHT.
Historical 004 source appraisal of 1 October 2026 reused; scope is stated in the title and source dossier, not fresh full-source access.
- 7LiGHT corrigendum 2025, DOI 10.1016/j.ophtha.2025.07.029
Historical 165 record of located corrigendum reused; no inferred correction content or fresh full corrected tables.
- 8Brandt et al. Adjusting IOP for CCT does not improve OHTS prediction models (2012). PMID: 21705084.
Historical 005 source record (3–6 October 2026), not new full-source access: Original full text on the trial website inspected on 3 October 2026, methods and Table 3. Model reanalysis, not a randomised comparison of correction strategies; CCT remains clinically informative.
Original lecture link
For patients
Glaucoma can damage the optic nerve even when one pressure reading seems normal. Several examinations are needed to distinguish disease, risk and another cause of visual problems.
Examination and selected tests guide individual treatment and follow-up; this educational text cannot replace your own assessment.
Sudden visual loss, severe pain, a red eye with high pressure, new neurological signs or suspected neovascular angle closure needs urgent assessment. Do not wait 2–3 months because of a braking metaphor.
Sudden visual loss, severe pain, a red eye with high pressure, new neurological signs or suspected neovascular angle closure needs urgent assessment. Do not wait 2–3 months because of a braking metaphor.